Nationwide cohort study reports remdesivir effectiveness in COVID-19 with severe renal insufficiency, highlighting critical gaps in clinical evidence.
The effectiveness of remdesivir in patients with coronavirus disease 2019 (COVID-19) and severe renal insufficiency remains underexplored.
No takes yet. Share an insight, caveat, or question.
Yamada et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: